Urteste SA (URT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.441x

Based on the latest financial reports, Urteste SA (URT) has a cash flow conversion efficiency ratio of 0.441x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł9.55 Million ≈ $2.63 Million USD) by net assets (zł21.64 Million ≈ $5.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Urteste SA - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Urteste SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Urteste SA for a breakdown of total debt and financial obligations.

Urteste SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Urteste SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
EAT WELL INVESTMENT GROUP
F:6BC0
N/A
Vincit Group Oyj
HE:VINCIT
-0.010x
Predictive Oncology Inc
NASDAQ:POAI
0.021x
Prairie Provident Resources Inc
TO:PPR
0.195x
Dignitana AB
ST:DIGN
-0.115x
Salee Colour Public Company Limited
BK:COLOR
0.017x
MyTech Group Bhd
KLSE:7692
0.134x
Inovalis Real Estate Investment Trust
TO:INO-UN
0.021x

Annual Cash Flow Conversion Efficiency for Urteste SA (2019–2024)

The table below shows the annual cash flow conversion efficiency of Urteste SA from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Urteste SA (URT) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 zł24.11 Million
≈ $6.64 Million
zł-5.47 Million
≈ $-1.50 Million
-0.227x -18.22%
2023-12-31 zł27.74 Million
≈ $7.64 Million
zł-5.32 Million
≈ $-1.46 Million
-0.192x +71.57%
2022-12-31 zł5.62 Million
≈ $1.55 Million
zł-3.79 Million
≈ $-1.04 Million
-0.675x -154.05%
2021-12-31 zł9.69 Million
≈ $2.67 Million
zł-2.57 Million
≈ $-708.19K
-0.266x +73.22%
2020-12-31 zł1.37 Million
≈ $375.68K
zł-1.35 Million
≈ $-372.56K
-0.992x -197.46%
2019-12-31 zł1.20 Million
≈ $328.95K
zł-398.48K
≈ $-109.67K
-0.333x --

About Urteste SA

WAR:URT Poland Biotechnology
Market Cap
$18.56 Million
zł67.45 Million PLN
Market Cap Rank
#25365 Global
#259 in Poland
Share Price
zł44.20
Change (1 day)
-0.90%
52-Week Range
zł28.40 - zł81.00
All Time High
zł180.00
About

Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus, ovary, endometrium, blood, breast, and brain. The company was incorporated in 2021 and is based in Gdansk, Poland.